Literature DB >> 24910195

Components of cancer metabolism and therapeutic interventions.

John Singleterry1, Annapoorna Sreedhar2, Yunfeng Zhao3.   

Abstract

All forms of life share a common indispensible need of energy. The requirement of energy is necessary for an organism not only to survive but also to thrive. The metabolic activities in normal cells rely predominately on mitochondrial oxidative phophorylation for energy generation in the form of ATP. On the contrary, cancer cells predominately rely on glycolysis rather than oxidative phosphorylation. It is long believed that an impairment of mitochondrial oxidative phosphorylation is the cause of this glycolytic phenotype observed in cancers. However, studies in cancer metabolism have revealed that mitochondrial function in many cancers is intact. It has also been observed that cancers utilize various forms of metabolism. The various metabolic phenotypes that are employed by cancer cells have a common purpose, to balance macromolecular biosynthesis and sufficient ATP production in order to support the rapid proliferation rate characteristic of these aberrant cells. These metabolic pathways are attractive targets for possible therapeutic interventions and currently research is underway to meet this end. More importantly, normal cells have essentially the same metabolic requirements as cancer cells so finding an approach to target these metabolic pathways without incurring detrimental effects on normal tissues remains the challenge.
Copyright © 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Cancer metabolism; Glycolysis; Mitochondria

Mesh:

Substances:

Year:  2014        PMID: 24910195      PMCID: PMC4134411          DOI: 10.1016/j.mito.2014.05.010

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  68 in total

1.  Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations.

Authors:  Luis G Carvajal-Carmona; N Afrina Alam; Patrick J Pollard; Angela M Jones; Ella Barclay; Noel Wortham; Massimo Pignatelli; Alex Freeman; Sabine Pomplun; Ian Ellis; Richard Poulsom; Mona A El-Bahrawy; Daniel M Berney; Ian P M Tomlinson
Journal:  J Clin Endocrinol Metab       Date:  2006-06-06       Impact factor: 5.958

2.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

3.  High dose vitamin K3 infusion in advanced hepatocellular carcinoma.

Authors:  Shiv K Sarin; Manoj Kumar; Sanjay Garg; Syed Hissar; Chandana Pandey; Barjesh C Sharma
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

4.  Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells.

Authors:  Michael Guppy; Peter Leedman; XinLin Zu; Victoria Russell
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 5.  Energy metabolism in tumor cells.

Authors:  Rafael Moreno-Sánchez; Sara Rodríguez-Enríquez; Alvaro Marín-Hernández; Emma Saavedra
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

6.  Mitochondrial impairment in p53-deficient human cancer cells.

Authors:  Shaoyu Zhou; Sushant Kachhap; Keshav K Singh
Journal:  Mutagenesis       Date:  2003-05       Impact factor: 3.000

7.  Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.

Authors:  Dewi Astuti; Niki Hart-Holden; Farida Latif; Fiona Lalloo; Graeme C Black; Caron Lim; Anthony Moran; Ashley B Grossman; Shirley V Hodgson; Anthony Freemont; Richard Ramsden; Charis Eng; D Gareth R Evans; Eamonn R Maher
Journal:  Clin Endocrinol (Oxf)       Date:  2003-12       Impact factor: 3.478

8.  Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism.

Authors:  Helene Pelicano; Weiqin Lu; Yan Zhou; Wan Zhang; Zhao Chen; Yumin Hu; Peng Huang
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Principles of cancer therapy: oncogene and non-oncogene addiction.

Authors:  Ji Luo; Nicole L Solimini; Stephen J Elledge
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

10.  FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.

Authors:  Max Hasmann; Isabel Schemainda
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  14 in total

Review 1.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

Review 2.  VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation.

Authors:  Diana Fang; Eduardo N Maldonado
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

3.  ATP/ADP Turnover and Import of Glycolytic ATP into Mitochondria in Cancer Cells Is Independent of the Adenine Nucleotide Translocator.

Authors:  Eduardo N Maldonado; David N DeHart; Jyoti Patnaik; Sandra C Klatt; Monika Beck Gooz; John J Lemasters
Journal:  J Biol Chem       Date:  2016-07-25       Impact factor: 5.157

Review 4.  ATP/ADP ratio, the missed connection between mitochondria and the Warburg effect.

Authors:  Eduardo N Maldonado; John J Lemasters
Journal:  Mitochondrion       Date:  2014-09-16       Impact factor: 4.160

5.  Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.

Authors:  Atsushi Hamabe; Hirofumi Yamamoto; Masamitsu Konno; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Tsunekazu Mizushima; Naohiro Nishida; Koichi Kawamoto; Jun Koseki; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Cancer Sci       Date:  2014-09-16       Impact factor: 6.716

6.  A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma.

Authors:  Varda Shoshan-Barmatz; Yael Bishitz; Avijit Paul; Yakov Krelin; Itay Nakdimon; Nir Peled; Avia Lavon; Elina Rudoy-Zilberman; Yael Refaely
Journal:  Oncotarget       Date:  2017-11-06

Review 7.  VDAC-Tubulin, an Anti-Warburg Pro-Oxidant Switch.

Authors:  Eduardo N Maldonado
Journal:  Front Oncol       Date:  2017-01-23       Impact factor: 6.244

Review 8.  Structure, Activity Regulation, and Role of the Mitochondrial Calcium Uniporter in Health and Disease.

Authors:  Cristina Mammucari; Gaia Gherardi; Rosario Rizzuto
Journal:  Front Oncol       Date:  2017-07-10       Impact factor: 6.244

9.  Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.

Authors:  Tao Tao; Ming Chen; Ranran Jiang; Han Guan; Yeqing Huang; Huan Su; Qiang Hu; Xu Han; Jun Xiao
Journal:  Oncol Rep       Date:  2017-02-07       Impact factor: 3.906

10.  Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cells.

Authors:  Rong Zhang; Guobing Li; Qian Zhang; Qin Tang; Jingbin Huang; Changpeng Hu; Yali Liu; Qing Wang; Wuyi Liu; Ning Gao; Shiwen Zhou
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.